| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |